Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell lines

被引:168
作者
Montaner, B
Navarro, S
Piqué, M
Vilaseca, M
Martinell, M
Giralt, E
Gil, J
Pérez-Tomás, R
机构
[1] Univ Barcelona, Dept Biol Cellular & Anat Patol, Unitat Proliferacio & Diferenciacio Cellular, Barcelona, Spain
[2] Univ Barcelona, Dept Ciencies Fisiol 2, Unitat Bioquim, Barcelona, Spain
[3] Univ Barcelona, Lab Espectrometria Masses, Barcelona, Spain
[4] Univ Barcelona, Dept Quim Organ, Barcelona, Spain
关键词
apoptosis; cancer cell lines; chemotherapy; immunosuppressor; prodigiosin;
D O I
10.1038/sj.bjp.0703614
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of supernatant from the bacterial strain Serratia marcescens 2170 (CS-2170) on the viability of different haematopoietic cancer cell lines (Jurkat, NSO, HL-60 and Ramos) and nonmalignant cells (NIH-3T3 and MDCK) was studied. We examined whether this cytotoxic effect was due to apoptosis, and we purified the molecule responsible for this effect and determined its chemical structure. 2 Using an MTT assay we showed a rapid (4 h) decrease in the number of viable cells. This cytotoxic effect was due to apoptosis, according to the fragmentation pattern of DNA, Hoechst 33342 staining and FAGS analysis of the phosphatidylserine externalization. This apoptosis was blocked by using the caspase inhibitor Z-VAD.fmk, indicating the involvement of caspases. 3 Prodigiosin is a red pigment produced by various bacteria including S. marcescens. Using mutants of S. marcescens (OF, WF and 933) that do not synthesize prodigiosin, we further showed that prodigiosin is involved in this apoptosis. This evidence was corroborated by spectroscopic analysis of prodigiosin isolated from S. marcescens. 4 These results indicate that prodigiosin, an immunosuppressor, induces apoptosis in haematopoietic cancer cells with no marked toxicity in nonmalignant cells, raising the possibility of its therapeutic use as an antineoplastic drug.
引用
收藏
页码:585 / 593
页数:9
相关论文
共 47 条
[1]  
Arab S, 1999, ONCOL RES, V11, P33
[2]   Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells [J].
Arab, S ;
Murakami, M ;
Dirks, P ;
Boyd, B ;
Hubbard, SL ;
Lingwood, CA ;
Rutka, JT .
JOURNAL OF NEURO-ONCOLOGY, 1998, 40 (02) :137-150
[3]   Induction of apoptosis of activated murine splenic T cells by cycloprodigiosin hydrochloride, a novel immunosuppressant [J].
Azuma, T ;
Watanabe, N ;
Yagisawa, H ;
Hirata, K ;
Iwamura, M ;
Kobayashi, Y .
IMMUNOPHARMACOLOGY, 2000, 46 (01) :29-37
[4]   Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells [J].
Bellosillo, B ;
Dalmau, M ;
Colomer, D ;
Gil, J .
BLOOD, 1997, 89 (09) :3378-3384
[5]   Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells [J].
Bellosillo, B ;
Piqué, M ;
Barragán, M ;
Castaño, E ;
Villamor, N ;
Colomer, D ;
Montserrat, E ;
Pons, G ;
Gil, J .
BLOOD, 1998, 92 (04) :1406-1414
[6]   TOTAL SYNTHESIS OF PRODIGIOSIN, PRODIGIOSENE, AND DESMETHOXYPRODIGIOSIN - DIELS-ALDER REACTIONS OF HETEROCYCLIC AZADIENES AND DEVELOPMENT OF AN EFFECTIVE PALLADIUM(II)-PROMOTED 2,2'-BIPYRROLE COUPLING PROCEDURE [J].
BOGER, DL ;
PATEL, M .
JOURNAL OF ORGANIC CHEMISTRY, 1988, 53 (07) :1405-1415
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]  
Brown JM, 1999, CANCER RES, V59, P1391
[9]   Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[10]  
Cameron R., 2000, HDB EXPT PHARM, V142